• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

被端孢霉属转化的人参二醇型皂苷 Rb₁和 Rg₁生成稀有人参皂苷 C-K 和 F₁。

Co-transformation of Panax major ginsenosides Rb₁ and Rg₁ to minor ginsenosides C-K and F₁ by Cladosporium cladosporioides.

机构信息

Key Laboratory of Natural Resources of Changbai Mountain and Functional Molecules, Ministry of Education, Yan Bian University, Gongyuan Road, Yanji 133002, Jilin, China.

出版信息

J Ind Microbiol Biotechnol. 2012 Apr;39(4):521-7. doi: 10.1007/s10295-011-1058-9. Epub 2012 Jan 20.

DOI:10.1007/s10295-011-1058-9
PMID:22270887
Abstract

Rb₁ and Rg₁ are the major ginsenosides in protopanaxadiol and protopanaxatriol. Their content in ginsenosides was 23.8 and 17.6%, respectively. A total of 22 isolates of β-glucosidase producing microorganisms were isolated from the soil of a ginseng field using Esculin-R2A agar. Among these isolates, the strain GH21 showed the strongest activities to convert ginsenoside Rb₁ and Rg₁ to minor ginsenosides compound-K and F₁, respectively. Ginsenosides Rb₁ and Rg₁ bioconversion rates were 74.2 and 89.3%, respectively. Meanwhile, the results demonstrated that the ginsenoside Rg₁ could change the biotransformation pathway of ginsenoside Rb₁ by inhibiting the formation of the intermediate metabolite gypenoside-XVII. GH21 was identified as a Cladosporium cladosporioides species based on the internal transcribed spacers (ITS) ITS1-5.8S-ITS2 rRNA gene sequences constructed phylogenetic trees.

摘要

Rb₁和 Rg₁是原二醇和原三醇型人参皂苷中的主要成分,其含量分别为 23.8%和 17.6%。从人参地土壤中用 Esculin-R2A 琼脂分离到 22 株产β-葡萄糖苷酶的微生物分离株。在这些分离株中,菌株 GH21 对转化人参皂苷 Rb₁和 Rg₁分别生成次要人参皂苷化合物-K 和 F₁的活性最强。人参皂苷 Rb₁和 Rg₁的转化率分别为 74.2%和 89.3%。同时,结果表明,人参皂苷 Rg₁通过抑制中间体代谢物人参皂苷 XVII 的形成改变了人参皂苷 Rb₁的生物转化途径。GH21 根据内部转录间隔区(ITS)ITS1-5.8S-ITS2 rRNA 基因序列构建的系统发育树被鉴定为棒曲霉(Cladosporium cladosporioides)种。

相似文献

1
Co-transformation of Panax major ginsenosides Rb₁ and Rg₁ to minor ginsenosides C-K and F₁ by Cladosporium cladosporioides.被端孢霉属转化的人参二醇型皂苷 Rb₁和 Rg₁生成稀有人参皂苷 C-K 和 F₁。
J Ind Microbiol Biotechnol. 2012 Apr;39(4):521-7. doi: 10.1007/s10295-011-1058-9. Epub 2012 Jan 20.
2
Highly selective microbial transformation of major ginsenoside Rb1 to gypenoside LXXV by Esteya vermicola CNU120806.Esteya vermicola CNU120806 对人参皂苷 Rb1 的高选择性微生物转化为绞股蓝皂苷 LXXV。
J Appl Microbiol. 2012 Oct;113(4):807-14. doi: 10.1111/j.1365-2672.2012.05400.x. Epub 2012 Aug 8.
3
Microbial conversion of major ginsenoside rb(1) to pharmaceutically active minor ginsenoside rd.主要人参皂苷Rb(1)向具有药学活性的次要人参皂苷Rd的微生物转化
J Microbiol. 2005 Oct;43(5):456-62.
4
Biotransformation of ginsenoside Rb1 to ginsenoside C-K by endophytic fungus Arthrinium sp. GE 17-18 isolated from Panax ginseng.从人参中分离出的内生真菌Arthrinium sp. GE 17-18将人参皂苷Rb1生物转化为人参皂苷C-K。
Lett Appl Microbiol. 2016 Sep;63(3):196-201. doi: 10.1111/lam.12606.
5
Characterization of the ginsenoside-transforming recombinant β-glucosidase from Actinosynnema mirum and bioconversion of major ginsenosides into minor ginsenosides.从美丽放线菌中鉴定人参皂苷转化重组β-葡萄糖苷酶及主要人参皂苷向次要人参皂苷的生物转化。
Appl Microbiol Biotechnol. 2013 Jan;97(2):649-59. doi: 10.1007/s00253-012-4324-5. Epub 2012 Aug 22.
6
Enhanced Production of Gypenoside LXXV Using a Novel Ginsenoside-Transforming β-Glucosidase from Ginseng-Cultivating Soil Bacteria and Its Anti-Cancer Property.利用从人参种植土壤细菌中分离的新型人参皂苷转化β-葡萄糖苷酶提高绞股蓝皂苷LXXV的产量及其抗癌特性
Molecules. 2017 May 19;22(5):844. doi: 10.3390/molecules22050844.
7
Diversity of cultivable β-glycosidase-producing micro-organisms isolated from the soil of a ginseng field and their ginsenosides-hydrolysing activity.从人参种植地土壤中分离出的可培养β-糖苷酶产生微生物的多样性及其对人参皂苷的水解活性。
Lett Appl Microbiol. 2014 Feb;58(2):138-44. doi: 10.1111/lam.12166. Epub 2013 Oct 21.
8
Identification and characterization of a novel Terrabacter ginsenosidimutans sp. nov. beta-glucosidase that transforms ginsenoside Rb1 into the rare gypenosides XVII and LXXV.鉴定和表征一种新型的土壤杆菌属(Terrabacter) Ginsenosidimutans sp. nov.β-葡萄糖苷酶,它能将人参皂苷 Rb1 转化为罕见的人参皂苷 XVII 和 LXXV。
Appl Environ Microbiol. 2010 Sep;76(17):5827-36. doi: 10.1128/AEM.00106-10. Epub 2010 Jul 9.
9
Enhanced biotransformation of the minor ginsenosides in red ginseng extract by Penicillium decumbens β-glucosidase.斜卧青霉β-葡萄糖苷酶增强红参提取物中次要人参皂苷的生物转化
Enzyme Microb Technol. 2022 Jan;153:109941. doi: 10.1016/j.enzmictec.2021.109941. Epub 2021 Nov 10.
10
Microbial conversion of ginsenoside Rb1 to minor ginsenoside F2 and gypenoside XVII by Intrasporangium sp. GS603 isolated from soil.从土壤中分离出的内孢囊菌属GS603菌株将人参皂苷Rb1微生物转化为次要人参皂苷F2和绞股蓝皂苷XVII。
J Microbiol Biotechnol. 2007 Dec;17(12):1937-43.

引用本文的文献

1
Production of rare ginsenosides by biotransformation of Panax notoginseng saponins using Aspergillus fumigatus.利用烟曲霉对三七皂苷进行生物转化生产稀有人参皂苷
Bioresour Bioprocess. 2024 Aug 9;11(1):81. doi: 10.1186/s40643-024-00794-0.
2
Biotransformation approach to produce rare ginsenosides F1, compound Mc1, and Rd2 from major ginsenosides.生物转化法从主要人参皂苷中生产罕见的人参皂苷 F1、化合物 Mc1 和 Rd2。
Arch Microbiol. 2024 Mar 17;206(4):176. doi: 10.1007/s00203-024-03893-w.
3
Transformation of Ginsenosides by MB11 Fermentation: Minor Ginsenosides Conversion and Enhancement of Anti-Colorectal Cancer Activity.

本文引用的文献

1
Microbial conversion of ginsenoside Rb1 to minor ginsenoside F2 and gypenoside XVII by Intrasporangium sp. GS603 isolated from soil.从土壤中分离出的内孢囊菌属GS603菌株将人参皂苷Rb1微生物转化为次要人参皂苷F2和绞股蓝皂苷XVII。
J Microbiol Biotechnol. 2007 Dec;17(12):1937-43.
2
Microbial transformation of ginsenoside Rb(1) by Acremonium strictum.枝状枝顶孢霉对人参皂苷Rb(1)的微生物转化
Appl Microbiol Biotechnol. 2008 Jan;77(6):1345-50. doi: 10.1007/s00253-007-1258-4. Epub 2007 Nov 27.
3
Ginsenoside Rd production from the major ginsenoside Rb(1) by beta-glucosidase from Thermus caldophilus.
MB11 发酵对人参皂苷的转化:低含量人参皂苷的转化及增强抗结直肠癌细胞活性。
Molecules. 2023 Dec 20;29(1):27. doi: 10.3390/molecules29010027.
4
American Ginseng for the Treatment of Alzheimer's Disease: A Review.西洋参治疗老年痴呆症的研究进展。
Molecules. 2023 Jul 28;28(15):5716. doi: 10.3390/molecules28155716.
5
Progress in the Conversion of Ginsenoside Rb1 into Minor Ginsenosides Using β-Glucosidases.利用β-葡萄糖苷酶将人参皂苷Rb1转化为次要人参皂苷的研究进展。
Foods. 2023 Jan 13;12(2):397. doi: 10.3390/foods12020397.
6
A review for discovering bioactive minor saponins and biotransformative metabolites in L.一篇关于发现L.中生物活性次要皂苷和生物转化代谢产物的综述
Front Pharmacol. 2022 Aug 1;13:972813. doi: 10.3389/fphar.2022.972813. eCollection 2022.
7
Functional Mechanism of Ginsenoside Compound K on Tumor Growth and Metastasis.人参皂苷Compound K 对肿瘤生长和转移的作用机制。
Integr Cancer Ther. 2022 Jan-Dec;21:15347354221101203. doi: 10.1177/15347354221101203.
8
A narrative review of the pharmacology of ginsenoside compound K.人参皂苷Compound K的药理学叙述性综述。
Ann Transl Med. 2022 Feb;10(4):234. doi: 10.21037/atm-22-501.
9
Influence of the plant growth promoting on aluminum resistance in .植物生长促进对……中耐铝性的影响。 你提供的原文似乎不完整,“in.”后面应该还有具体内容。
J Ginseng Res. 2021 May;45(3):442-449. doi: 10.1016/j.jgr.2020.01.001. Epub 2020 Jan 8.
10
SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway.SGL121 通过调节 AMPK 信号通路改善非酒精性脂肪肝病的脂质代谢。
Int J Mol Sci. 2020 Jun 25;21(12):4534. doi: 10.3390/ijms21124534.
嗜热栖热菌β-葡萄糖苷酶从主要人参皂苷Rb(1)生产人参皂苷Rd
Biotechnol Lett. 2008 Apr;30(4):713-6. doi: 10.1007/s10529-007-9590-4. Epub 2007 Nov 8.
4
Transformation of bioactive compounds by Fusarium sacchari fungus isolated from the soil-cultivated ginseng.从种植于土壤中的人参中分离出的甘蔗镰刀菌对生物活性化合物的转化作用
J Agric Food Chem. 2007 Nov 14;55(23):9373-9. doi: 10.1021/jf070354a. Epub 2007 Oct 13.
5
Ginsenosides compound K and Rh(2) inhibit tumor necrosis factor-alpha-induced activation of the NF-kappaB and JNK pathways in human astroglial cells.人参皂苷Compound K和Rh(2)抑制肿瘤坏死因子-α诱导的人星形胶质细胞中NF-κB和JNK信号通路的激活。
Neurosci Lett. 2007 Jun 21;421(1):37-41. doi: 10.1016/j.neulet.2007.05.017. Epub 2007 May 22.
6
Conversion of major ginsenoside Rb1 to ginsenoside F2 by Caulobacter leidyia.莱迪氏柄杆菌将主要人参皂苷Rb1转化为人参皂苷F2 。
Biotechnol Lett. 2006 Jul;28(14):1121-7. doi: 10.1007/s10529-006-9059-x. Epub 2006 Jun 21.
7
Microbial conversion of major ginsenoside rb(1) to pharmaceutically active minor ginsenoside rd.主要人参皂苷Rb(1)向具有药学活性的次要人参皂苷Rd的微生物转化
J Microbiol. 2005 Oct;43(5):456-62.
8
Transformation of ginsenosides Rb2 and Rc from Panax ginseng by food microorganisms.人参中人参皂苷Rb2和Rc被食品微生物转化。
Biol Pharm Bull. 2005 Nov;28(11):2102-5. doi: 10.1248/bpb.28.2102.
9
Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury.人参皂苷Rb1和化合物K对叔丁基过氧化氢诱导的肝损伤的保肝作用。
Liver Int. 2005 Oct;25(5):1069-73. doi: 10.1111/j.1478-3231.2005.01068.x.
10
Transformation of ginsenosides Rb1 and Re from Panax ginseng by food microorganisms.人参中人参皂苷Rb1和Re被食品微生物转化。
Biotechnol Lett. 2005 Jun;27(11):765-71. doi: 10.1007/s10529-005-5632-y.